A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors

详细信息    查看全文

• 作者：Peiliang Geng ; Juanjuan Ou ; Jianjun Li ; Yunmei Liao ; Ning Wang…
• 关键词：ERCC1 ; ERCC2 ; ERCC5 ; Brain tumor ; Glioma ; Single nucleotide polymorphisms
• 刊名：Molecular Neurobiology
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：53
• 期：4
• 页码：2705-2714
• 全文大小：537 KB
• 参考文献：1.Dolecek TA et al (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncology 14(Suppl 5):v1–49CrossRef PubMed PubMedCentral
  2.Bondy ML et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113(7 Suppl):1953–68CrossRef PubMed PubMedCentral
  3.Hemminki K et al (2009) Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol 10(5):481–8CrossRef PubMed
  4.Shete S et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41(8):899–904CrossRef PubMed PubMedCentral
  5.Li S et al (2012) Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. Cancer Epidemiol 36(3):283–7CrossRef PubMed
  6.Silva MM et al (2013) Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy. Genet Mol Res 12(2):1621–30CrossRef PubMed
  7.Hienonen T et al (2005) Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers. Cancer Res 65(11):4607–13CrossRef PubMed
  8.Lovejoy CA et al (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8(7):e1002772CrossRef PubMed PubMedCentral
  9.Chen P et al (2000) Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 9(8):843–7PubMed
  10.Shields PG, Harris CC (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18(11):2309–15PubMed
  11.Hemminki K, Thilly WG (2004) Implications of results of molecular epidemiology on DNA adducts, their repair and mutations for mechanisms of human cancer. IARC Sci Publ 157:217–35PubMed
  12.Leibeling D, Laspe P, Emmert S (2006) Nucleotide excision repair and cancer. J Mol Histol 37(5–7):225–38CrossRef PubMed
  13.Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11(12):1513–30PubMed
  14.Caggana M et al (2001) Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev 10(4):355–60PubMed
  15.Chen DQ et al (2012) DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis. Asian Pac J Cancer Prev 13(6):2791–4CrossRef PubMed
  16.Liu Y et al (2009) Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 18(1):204–14CrossRef PubMed PubMedCentral
  17.Luo KQ et al (2013) Polymorphisms in DNA repair genes and risk of glioma and meningioma. Asian Pac J Cancer Prev 14(1):449–52CrossRef PubMed
  18.McKean-Cowdin R et al (2009) Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 18(4):1118–26CrossRef PubMed PubMedCentral
  19.Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–48PubMed
  20.DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–88CrossRef PubMed
  21.Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–58CrossRef PubMed
  22.Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–34CrossRef PubMed PubMedCentral
  23.Zhang N et al (2012) ERCC1 polymorphisms and risk of adult glioma in a Chinese population: a hospital-based case-control study. Cancer Investig 30(3):199–202CrossRef
  24.Salnikova LE et al (2010) Association study of xenobiotic detoxication and repair genes with malignant brain tumors in children. Acta Nat 2(4):58–65
  25.Cheng HB et al (2013) Xeroderma pigmentosum complementation group f polymorphisms influence risk of glioma. Asian Pac J Cancer Prev 14(7):4083–7CrossRef PubMed
  26.Yang P et al (2005) Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas. Cancer 103(11):2363–72CrossRef PubMed
  27.Lupo PJ et al (2012) An exploratory case-only analysis of gene-hazardous air pollutant interactions and the risk of childhood medulloblastoma. Pediatr Blood Cancer 59(4):605–10CrossRef PubMed PubMedCentral
  28.Pan WR, Li G, Guan JH (2013) Polymorphisms in DNA repair genes and susceptibility to glioma in a chinese population. Int J Mol Sci 14(2):3314–24CrossRef PubMed PubMedCentral
  29.Rajaraman P et al (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncology 12(1):37–48CrossRef PubMed PubMedCentral
  30.Wang XF, Liu S, Shao ZK (2013) Effects of polymorphisms in nucleotide excision repair genes on glioma risk in a Chinese population. Gene 529(2):317–20CrossRef PubMed
  31.Wrensch M et al (2005) ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncology 7(4):495–507CrossRef PubMed PubMedCentral
  32.Yang D (2005) L.Q., Zhang YZ, Wang HY, Luo YN, et al., Comparison of screen for single nucleotide polymorphisms of the glioma susceptibility gene -ERCC2 by using denaturing high performance liquid chromatography and restriction fragment length polymorphism. Chinese J Minim Invasive Neurosurg 10:164–166
  33.Salnikova LE et al (2013) The potential effect of gender in CYP1A1 and GSTM1 genotype-specific associations with pediatric brain tumor. Tumour Biol 34(5):2709–19CrossRef PubMed
  34.Dong YS et al (2014) Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population. Tumour Biol 35(5):4937–41CrossRef PubMed
  35.Hui L et al (2014) Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk. Tumour Biol 35(8):7451–7CrossRef PubMed
  36.Rodriguez-Hernandez I et al (2014) Analysis of DNA repair gene polymorphisms in glioblastoma. Gene 536(1):79–83CrossRef PubMed
  37.Friedberg EC (2001) How nucleotide excision repair protects against cancer. Nat Rev Cancer 1(1):22–33CrossRef PubMed
  38.Rass K, Reichrath J (2008) UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 624:162–78CrossRef PubMed
  39.Lu B et al (2014) Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA. Gene 542(1):64–8CrossRef PubMed
  40.Barry KH et al (2012) Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk. Carcinogenesis 33(2):331–7CrossRef PubMed PubMedCentral
  41.Zhang L et al (2012) Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis. Mutagenesis 27(1):67–76CrossRef PubMed
  42.Gallego Perez-Larraya, J. and J.Y. Delattre, Management of Elderly Patients With Gliomas. Oncologist, 2014
  43.Gulati S et al (2012) Survival and treatment patterns of glioblastoma in the elderly: a population-based study. World Neurosurg 78(5):518–26CrossRef PubMed
  44.Xu Z et al (2014) Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis. Tumour Biol 35(4):3211–21CrossRef PubMed
  45.Yuan G et al (2014) DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma. Tumour Biol 35(5):4267–75CrossRef PubMed
  46.Adel Fahmideh M et al (2014) Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncology 16(6):807–14CrossRef PubMed PubMedCentral
  47.Wrensch M et al (1993) Environmental risk factors for primary malignant brain tumors: a review. J Neuro Oncol 17(1):47–64CrossRef
  48.Ohgaki H (2009) Epidemiology of brain tumors. Methods Mol Biol 472:323–42CrossRef PubMed
  49.Hirschhorn JN et al (2002) A comprehensive review of genetic association studies. Genet Med 4(2):45–61CrossRef PubMed
  
• 作者单位：Peiliang Geng (1)
  Juanjuan Ou (1)
  Jianjun Li (1)
  Yunmei Liao (1)
  Ning Wang (1)
  Ganfeng Xie (1)
  Rina Sa (1)
  Chen Liu (1)
  Lisha Xiang (1)
  Houjie Liang (1)
  
  1. Department of Oncology and Southwest Cancer Center, Southwest Hospital Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China
  
• 刊物主题：Neurosciences; Neurobiology; Cell Biology; Neurology;
• 出版者：Springer US
• ISSN：1559-1182

文摘

Within DNA repair genes, there lie a number of single nucleotide polymorphisms that may impair protein function and attenuate DNA repair capability, resulting in genomic instability and individual predisposition to malignancies. The purpose of this study was to assess the previously reported inconsistent association of polymorphisms in ERCC1 (rs11615, rs3212986), ERCC2 (rs13181, rs1799793, rs238406), and ERCC5 (rs17655) with the development of brain tumors. In the present work, we carried out a comprehensive meta-analysis of results from all published data (5 data sets for rs11615, 7 for rs3212986, 11 for rs13181, 5 for rs1799793, 3 for rs238406, and 4 for rs17655) to evaluate risk of brain tumors contributed by the polymorphisms being investigated. Either the analytic method described by Mantel and Haenszel or that proposed by DerSimonian and Laird was properly used to summarize the risk estimates (OR and 95 % CI). Data analyses were done with Stata version 12.0. Meta-analyses were performed for all polymorphisms, and only rs3212986 in the ERCC1 gene showed a significant association with glioma incidence. In the homozygote comparison, we found 1.26-fold elevated risk of glioma in relation to presence of the AA genotype (OR = 1.26, 95 % CI = 1.05–1.52, P _OR = 0.013, P _{heterogeneity} = 0.849, I 2 = 0.0 %). We also noted that individuals with the rs3212986-AA as compared to those with rs3212986-CC/CA had a 28 % higher risk to develop glioma (OR = 1.28, 95 % CI = 1.06–1.53, P _OR = 0.008, P _{heterogeneity} = 0.808, I 2 = 0.0 %). No major effects were observed for Caucasians or Asians in subgroup analysis by ethnicity. ERCC1 rs3212986 is a common single nucleotide polymorphism and may contribute toward individual susceptibility for glioma. Further research in this filed is required to verify the association obtained based on a relatively small number.